AN2 Therapeutics (ANTX) Stock: Buy, Sell, or Hold?
ANTX - AN2 Therapeutics, Inc. Common Stock
$4.85
-0.22 (-4.34%)
▼
5d:
-8.83%
30d:
-18.9%
90d:
+4.75%
HOLD
LOW Confidence
Analysis Updated: Oct 7, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When ANTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ANTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ANTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ANTX is currently trading at $4.85, which is considered slightly high relative to its 30-day fair value range of $5.03 to $5.76.
Technical Outlook: Technically, ANTX is in a uptrend. Immediate support is located at $4.67, while resistance sits at $5.99. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: ANTX scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.00 (+85.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ANTX is in a uptrend. Immediate support is located at $4.67, while resistance sits at $5.99. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: ANTX scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.00 (+85.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$5.03 -
$5.76
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 85.6% below Wall St target ($9.00)
- CAUTION: Bottoming setup, but lagging the sector by 24% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-8.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$5.03 -
$5.76
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.67
Resistance Level
$5.99
Current Trend
Uptrend
Technical data as of
Oct 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.06
Wall Street Target
$9.00
(+85.6%)
Share & Embed Analysis
Last updated: October 08, 2026 2:05 AM ET
Data refreshes hourly during market hours. Next update: 3:05 AM
Data refreshes hourly during market hours. Next update: 3:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
23 analysts |
$84 | 81 BUY |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 66 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$106 | 54 HOLD |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 55 HOLD |
